Literature DB >> 9831933

Systemic anti-inflammatory effect induced by counter-irritation through a local release of somatostatin from nociceptors.

J Szolcsányi1, E Pintér, Z Helyes, G Oroszi, J Németh.   

Abstract

1. Neurogenic plasma extravasation evoked by topical application of 1% vv(-1) mustard oil on the skin of the acutely denervated rat hindleg (primary reaction) inhibited the development of a subsequent oil-induced plasma extravasation induced in the skin of the contralateral hindleg by 49.3+/-7.06% (n=9) and in the conjunctival mucosa due to 0.1% wv(-1) capsaicin instillation by 33.5+/-10.05% (n=6). The primary reaction also inhibited the non-neurogenic hindpaw oedema evoked by s.c. injection of 5% wv(-1) dextran into the chronically denervated hindpaw by 48.0+/-4.6% (n= 5). 2. Capsaicin injection (100 microg ml(-1) in 50 microl, s.c.) into the acutely denervated hindleg caused 56.5+/-4.0% (n=5) inhibition in the intensity of plasma extravasation elicited by 1% vv(-1) mustard oil smearing on the contralateral side. After chronic denervation, subplantar injection of 5% wv(-1) dextran elicited a non-neurogenic inflammatory response with intensive tissue oedema without causing any systemic anti-inflammatory effect. Bilateral adrenalectomy did not inhibit the mustard oil-induced anti-inflammatory effect in the contralateral hindleg. 3. Pretreating the rats with polyclonal somatostatin antiserum (0.5 ml rat(-1), i.v.) or with the somatostatin depleting agent cysteamine (280 mg kg(-1), s.c.) prevented the inhibitory action of mustard oil-induced inflammation on subsequent neurogenic plasma extravasation and strongly diminished the inhibition of non-neurogenic oedema formation evoked by dextran. 4. Exogenous somatostatin (10 microg kg(-1), i.p.) caused a 30.3+/-8.3% (n=6) inhibition of plasma extravasation caused by mustard oil smearing on the acutely denervated hindleg and this inhibitory effect was abolished by somatostatin antiserum (0.5 ml rat(-1), i.v.). The plasma level of somatostatin-like immunoreactivity (SST-LI) increased by 40.03+/-6.8% (n= 6) 10 min after topical application of 1% vv(-1) mustard oil on the acutely denervated hindpaws compared to the paraffin oil treated control group. Chronic denervation of the hindlegs or cysteamine (280 mg kg(-1), s.c.) pretreatment prevented the mustard oil-induced elevation of SST-LI in plasma. 5. It is concluded that chemical excitation of the capsaicin-sensitive sensory receptors not only induces local neurogenic plasma extravasation but also inhibits the development of a subsequent inflammatory reaction at remote sites of the body in the rat. A role for somatostatin in this systemic anti-inflammatory effect is suggested.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831933      PMCID: PMC1571027          DOI: 10.1038/sj.bjp.0702144

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Tonic control of peripheral cutaneous nociceptors by somatostatin receptors.

Authors:  S M Carlton; J Du; S Zhou; R E Coggeshall
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  [Somatostatin - an important inhibitor of neuronal activity].

Authors:  G Segond von Banchet
Journal:  Schmerz       Date:  2008-08       Impact factor: 1.107

Review 3.  Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.

Authors:  Erika Pintér; Gábor Pozsgai; Zsófia Hajna; Zsuzsanna Helyes; János Szolcsányi
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

4.  Anti-inflammatory effect of synthetic somatostatin analogues in the rat.

Authors:  Z Helyes; E Pintér; J Németh; G Kéri; M Thán; G Oroszi; A Horváth; J Szolcsányi
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

5.  Analgesic effect of long-acting somatostatin receptor agonist pasireotide in a patient with acromegaly and intractable headaches.

Authors:  Christina M Lovato; Patricia L Kapsner
Journal:  BMJ Case Rep       Date:  2018-06-19

6.  N-Methylated sst2 Selective Somatostatin Cyclic Peptide Analogue as a Potent Candidate for Treating Neurogenic Inflammation.

Authors:  Jayanta Chatterjee; Burkhardt Laufer; Johannes G Beck; Zsuzsanna Helyes; Erika Pintér; János Szolcsányi; Aniko Horvath; Jozsef Mandl; Jean C Reubi; György Kéri; Horst Kessler
Journal:  ACS Med Chem Lett       Date:  2011-04-04       Impact factor: 4.345

7.  Calcium-dependent inhibition of T-type calcium channels by TRPV1 activation in rat sensory neurons.

Authors:  Valentina Comunanza; Emilio Carbone; Andrea Marcantoni; Emanuele Sher; Daniel Ursu
Journal:  Pflugers Arch       Date:  2011-09-09       Impact factor: 3.657

8.  Hot target on nociceptors: perspectives, caveats and unique features.

Authors:  J Szolcsányi
Journal:  Br J Pharmacol       Date:  2008-11-10       Impact factor: 8.739

9.  Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.

Authors:  Zsuzsanna Helyes; Erika Pintér; Katalin Sándor; Krisztián Elekes; Agnes Bánvölgyi; Dániel Keszthelyi; Eva Szoke; Dániel M Tóth; Zoltán Sándor; László Kereskai; Gábor Pozsgai; Jeremy P Allen; Piers C Emson; Adrienn Markovics; János Szolcsányi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

10.  Hepatic insulin sensitizing substance: a novel 'sensocrine' mechanism to increase insulin sensitivity in anaesthetized rats.

Authors:  Robert Porszasz; Gyorgyi Legvari; Tunde Pataki; Judith Szilvassy; Jozsef Nemeth; Peter Kovacs; Gyorgy Paragh; Janos Szolcsanyi; Zoltan Szilvassy
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.